Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

Top urologists share their insights and practical tips at "Urology on the Beach"

Top urologists share their insights and practical tips at "Urology on the Beach"

Cryo-electron microscopy captures the first 3D structure of SPOP protein that drives cancer

Cryo-electron microscopy captures the first 3D structure of SPOP protein that drives cancer

Cancer mortality in the U.S. has declined 33% since the 90s

Cancer mortality in the U.S. has declined 33% since the 90s

American Cancer Society's annual report on cancer facts and trends released

American Cancer Society's annual report on cancer facts and trends released

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

Study shows the prevalence of low-value prostate cancer screening in primary care clinics

Study shows the prevalence of low-value prostate cancer screening in primary care clinics

Weighing risks of a major surgery: 7 questions older Americans should ask their surgeon

Weighing risks of a major surgery: 7 questions older Americans should ask their surgeon

UTSW researchers identify molecular function of 87 inherited genetic variants linked to prostate cancer

UTSW researchers identify molecular function of 87 inherited genetic variants linked to prostate cancer

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

Rising Medicare costs linked to increased use of new prostate cancer therapies

Rising Medicare costs linked to increased use of new prostate cancer therapies

BGI cares - 2022 social responsibilities in review

BGI cares - 2022 social responsibilities in review

Imaging method yields highly accurate and precise values of radionuclide organ uptake

Imaging method yields highly accurate and precise values of radionuclide organ uptake

Genetic testing program could help to close the gap for some patients with prostate cancer

Genetic testing program could help to close the gap for some patients with prostate cancer

Exercise has many benefits even for people with advanced cancer

Exercise has many benefits even for people with advanced cancer

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Expansion of intermediate cells in prostate cancer correlates with treatment resistance and poor outcomes

Expansion of intermediate cells in prostate cancer correlates with treatment resistance and poor outcomes

Cambridge scientists develop a comprehensive tool for predicting individual's risk of prostate cancer

Cambridge scientists develop a comprehensive tool for predicting individual's risk of prostate cancer

Discovery of cellular uptake pathway for larger molecules can be harnessed to create new drugs

Discovery of cellular uptake pathway for larger molecules can be harnessed to create new drugs

New project aims to address the vast data-related problems in cancer research

New project aims to address the vast data-related problems in cancer research